Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco Dorsey Wright Momentum ETF
PDP
|
+$591M |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$240M |
| 3 |
Boston Scientific
BSX
|
+$194M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$193M |
| 5 |
Clarivate
CLVT
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.25B |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$809M |
| 3 |
Willis Towers Watson
WTW
|
+$664M |
| 4 |
AstraZeneca
AZN
|
+$658M |
| 5 |
Microsoft
MSFT
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.19% |
| 2 | Financials | 6.48% |
| 3 | Consumer Discretionary | 5.4% |
| 4 | Healthcare | 5.05% |
| 5 | Communication Services | 4.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4276
Harmony Biosciences
HRMY
$2.08B
| $112K | ﹤0.01% |
2,931
+785
| +37% | +$25.3K |
|
4277
Caesarstone
CSTE
$69.5M
| $111K | ﹤0.01% |
8,947
+558
| +7% | +$7.49K |
|
|
PARAA
4278
DELISTED
Paramount Global Class A
PARAA
| $111K | ﹤0.01% |
2,638
+33
| +1% | +$1.48K |
|
4279
Transmedics
TMDX
$2.7B
| $111K | ﹤0.01% |
3,342
+1,483
| +80% | +$45.3K |
|
|
GDEN
4280
DELISTED
Golden Entertainment
GDEN
| $110K | ﹤0.01% |
2,246
+748
| +50% | +$34.8K |
|
4281
Willdan Group
WLDN
$1.02B
| $110K | ﹤0.01% |
3,093
+1,336
| +76% | +$50.3K |
|
|
VVNT
4282
DELISTED
Vivint Smart Home, Inc. Class A Common Stock
VVNT
| $110K | ﹤0.01% |
11,590
-10,384
| -47% | -$124K |
|
|
ASPCU
4283
DELISTED
Alpha Capital Acquisition Co Unit
ASPCU
| $110K | ﹤0.01% |
10,921
| – | – |
|
4284
Expro Ltd
XPRO
$1.64B
| $109K | ﹤0.01% |
6,172
+1,801
| +41% | +$30.5K |
|
|
TWOA
4285
DELISTED
two
TWOA
| $109K | ﹤0.01% |
11,098
| – | – |
|
4286
CALL
New Oriental
EDU
$9.32B
| $108K | ﹤0.01% |
+5,250
| New | +$167K |
|
|
JPS
4287
DELISTED
Nuveen Preferred & Income Securities Fund
JPS
| $108K | ﹤0.01% |
11,049
-7,512
| -40% | -$75K |
|
4288
DHT Holdings
DHT
$2.99B
| $106K | ﹤0.01% |
16,210
+8,861
| +121% | +$51.3K |
|
4289
GFL Environmental
GFL
$14.5B
| $106K | ﹤0.01% |
2,840
+4
| +0.1% | +$138 |
|
|
KRON
4290
DELISTED
Kronos Bio
KRON
| $106K | ﹤0.01% |
5,046
+2,890
| +134% | +$62.1K |
|
|
OLO
4291
DELISTED
Olo Inc
OLO
| $106K | ﹤0.01% |
+3,541
| New | +$126K |
|
|
XM
4292
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
| $106K | ﹤0.01% |
2,490
-8,718
| -78% | -$369K |
|
4293
Gorman-Rupp
GRC
$2.07B
| $105K | ﹤0.01% |
2,936
+895
| +44% | +$31.7K |
|
|
HTBK
4294
DELISTED
Heritage Commerce
HTBK
| $105K | ﹤0.01% |
9,014
-24,877
| -73% | -$278K |
|
4295
Invivyd
IVVD
$160M
| $105K | ﹤0.01% |
+2,496
| New | +$92.6K |
|
4296
MINISO
MNSO
$3.88B
| $105K | ﹤0.01% |
6,862
-109,816
| -94% | -$1.68M |
|
|
GHL
4297
DELISTED
Greenhill & Co., Inc.
GHL
| $105K | ﹤0.01% |
7,216
-484
| -6% | -$7.2K |
|
4298
Daktronics
DAKT
$946M
| $104K | ﹤0.01% |
19,132
-1,519
| -7% | -$9.02K |
|
|
FFIC
4299
DELISTED
Flushing Financial
FFIC
| $104K | ﹤0.01% |
4,633
-15,190
| -77% | -$336K |
|
4300
Hackett Group
HCKT
$281M
| $104K | ﹤0.01% |
5,308
+2,252
| +74% | +$42.2K |
|
Similar funds
Citigroup's Q3 2021 Portfolio in Review
As of Q3 2021, Citigroup held 6,611 positions worth $169B, up 1.9% from $166B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Citigroup deployed $5.8B of net new capital in Q3 2021, opening 423 new positions and adding to 2,034 existing holdings. Its largest new stake was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.25B trimmed.
- Citigroup's largest Q3 2021 buy was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
- Citigroup added most to Invesco Dorsey Wright Momentum ETF in Q3 2021, an estimated $591M increase.
- Citigroup's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.25B.
- Citigroup fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $809M.
- Citigroup's ten largest holdings make up 25% of its $169B portfolio in Q3 2021.
- Citigroup opened 423 new positions and closed 793 in Q3 2021.
- Citigroup's portfolio value rose 1.9% quarter-over-quarter to $169B.
Based on Citigroup's 13F filing for Q3 2021, filed 10 Nov 2021.